Interestingly, the androgen-independent metastatic carcinoma cells in bone lesions and also nonosseous metastases regained ERβ expression, providing a critical foundation for developments of PCa therapy targeting this receptor for patients with relapses after androgen ablation therapy [115,131]. Here, ESR2 is linked to posterior cortical atrophy.